ArticleOsong public health and research perspectives2024
Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea.
Mijeong Ko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.